RHINOMED LIMITED (RNO)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

RNO - RHINOMED LIMITED

Year End: June
GICS Industry Group : Pharmaceuticals, Biotechnology & Life Sciences
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.36

22 Sep
2021

-0.020

OPEN

$0.37

-5.26%

HIGH

$0.38

141,048

LOW

$0.36

OTHER COMPANIES IN THE SAME SECTOR
CUV . ACR . AHZ . CSL . IDT . IVX . MSB . MYX . OSL . TFC . TIS . KZA . AGH . FTT . PAR . ADO . PYC . RAC . RCE . ZNO . AVH . LGP . SPL . ARX . AFP . 1AD . TLX . PNV . MVP . BNO . NXS . GSS . EOF . NEU . PAL . PBP . BOT . IMU . MDC . IMM . PXS . OPT . ANP .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2021 FactSet UK Limited. All rights reserved
Title 201620172018201920202021
EPS Basic xxxxxxxxxxxxxxx-3.4
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx3.9 M
Book Value Per Share xxxxxxxxxxxxxxx1.9
Net Operating Cash Flow xxxxxxxxxxxxxxx-5.3 M
Net Profit Margin xxxxxxxxxxxxxxx-221.80 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201620172018201920202021
Return on Assets xxxxxxxxxxxxxxx-89.24 %
Return on Equity xxxxxxxxxxxxxxx-110.60 %
Return on Total Capital xxxxxxxxxxxxxxx-100.87 %
Capex xxxxxxxxxxxxxxx0.0 M
Capex % of Sales xxxxxxxxxxxxxxx1.26 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-5.4 M

Return on Assets

Return on Equity

Return on Total Capital

Capex

Capex % of Sales

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

RNO STOCK CHART